Asia Pacific Patient Registry Software Market

Market Introduction

A patient registry is the database that collects uniform data about a population of disease or condition, and that aids a predefined clinical or scientific. Patient registry software contains databases that are maintained through collection of secondary data related to diagnosis, procedure, or condition of patient, for noting the number of new medical devices being used or going through a new procedure. The patient registry software plays a crucial role in post-marketing surveillance of pharmaceuticals.

Thus, a development of digital infrastructure in healthcare is expected to create a significant demand for patient registry software in the coming years, which is further anticipated to drive the patient registry software market.

Increasing burden on existing healthcare systems along with rising demand for advanced data collection and analysis technologies is expected to drive the Asia Pacific patient registry software market, even during the time of pandemic. In January 2021, BC Platforms, a significant player in clinical and genomic data management announced collaboration with Japan-based RIKEN research institution and the Finnish Institute for Health and Welfare (‘THL’). The company entered into this partnership for research and development of a precision prediction model in order to increase the patient detection for covid-19. Moreover, in September 2020, the government of India launched National Covid-19 Registry and a vaccine portal to keep track of covid-19 related activities. The registry focuses on collection of real-time clinical data with an aim to boost research and development. Further, pharmaceutical companies are also increasingly utilizing patient data to shorten the clinical-development cycle and decrease its costs. With greater number of regulatory agencies laying stress on value and patient outcome, patient engagement is expected to increase adoption of patient registry software in coming years.

Market Overview and Dynamics

The Asia Pacific patient registry software market is expected to grow from US$ 200.7 million in 2020 to US$ 452.3 million by 2027; it is estimated to grow at a CAGR of 12.3% from 2020 to 2027. The use of medical information from clinical registries is gradually increasing worldwide. Clinical registries capture broad-scope data by using a mixture of manual and automated methods. Further, in 2016, the National Quality Registry Network (NQRN) ruled out a list of registries based on publicly available sources. These registries focus on aspects such as quality improvement, population management benchmarking, comparative effective research (CER), family medicine, lung cancer screening, interventional radiology, and metabolic and bariatric surgery. The availability of free license for patient registries increases their adoption in healthcare centers. The availability of many disease registries helps doctors and other clinical professionals identify and compare all available practices, followed by adopting the best one; this process uplifts the performance of this healthcare sector, thereby bolstering the adoption of patient registry software.

Key Market Segments

In terms of software, the integrated segment accounted for the largest share of the Asia Pacific patient registry software market in 2019. In terms of database, the commercial segment held a larger market share of the patient registry software market in 2019. In terms of type of registry, the disease registry segment held a larger market share of the patient registry software market in 2019. In terms of mode of delivery, the cloud-based segment held a larger market share of the patient registry software market in 2019. In terms of pricing model, the subscription segment held a larger market share of the patient registry software market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the patient registry software market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are IQVIA Inc., Medstreaming, FIGmd Inc., Evado Clinical, Open Text Corporation, LUMEDX, IBM Corporation, Mckesson Corporation, and Dacima Software Inc.

Reasons to buy report

• To understand the Asia Pacific patient registry software market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific patient registry software market
• Efficiently plan M&A and partnership deals in Asia Pacific patient registry software market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific patient registry software market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.

ASIA PACIFIC PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION

By Software

• Standalone
• Integrated

By Database

• Public
• Commercial

By Type of Registry

• Product Registry
• Disease Registry
  • Cardiovascular Disease Registry
  • Others
• Health Service Registry

By Mode of Delivery

• On-Premises
• Cloud-Based

By Pricing Model

• Ownership
• Subscription

By Country

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

Companies Mentioned

1. IQVIA Inc.
2. Medstreaming
3. Open Text Corporation
4. LUMEDX
5. IBM Corporation
6. Mckesson Corporation
7. Dacima Software Inc
8. FIGmd Inc.
9. Evado Clinical

Asia Pacific Patient Registry Software Market Strategic Insights

Asia Pacific Patient Registry Software Market Segmentation Analysis

Asia Pacific Patient Registry Software Market Report Highlights

Asia Pacific Patient Registry Software Report Scope

Asia Pacific Patient Registry Software Market Country and Regional Insights